一般社団法人日本呼吸器学会 公式サイト
日本呼吸器学会英文誌 Respiratory Investigation
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集 検索用
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集 全文PDF

Abstract

Full Text of PDF Full Text of PDF (701k)  required ID / password
Article in Japanese

Case Report

A case of Hamman’s syndrome that presented with chest pain that developed after administration of SGLT2 inhibitors

Yoshinobu Naganoa  Manato Taguchia  Ryusei Nakagawab  Mao Sasamotoa  Takeshi Kawakamia  Kyoko Kondoa 

aDepartment of Respiratory Medicine, Kobari General Hospital
bDepartment of Respiratory Medicine, Ibaraki Seinan Medical Center Hospital

ABSTRACT

The patient was a 16-year-old man who had visited another hospital with a chief complaint of vomiting. He was diagnosed with type 2 diabetes and prescribed tofogliflozin.
Six days later, he became aware of chest pain and difficulty breathing and called for an ambulance. As a result of close examination, pneumomediastinum and diabetic ketoacidosis were detected, so he was diagnosed with Hamman’s syndrome and hospitalized. He required tracheal intubation and dialysis management but was discharged after improvement following an infusion and insulin treatment.
Only one case of Hamman’s syndrome involving SGLT2 inhibitors has been reported; we therefore present this case because we consider it to be valuable.

KEYWORDS

Pneumomediastinum  Diabetic ketoacidosis (DKA)  Hamman’s syndrome  Tofogliflozin 

Received 27 Apr 2023 / Accepted 10 Oct 2023

AJRS, 13(1): 39-43, 2024

Google Scholar